MedTrace Logo

Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy With Chronic Lung Diseases

NCT06385301 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-12-10

No results posted yet for this study

Summary

The investigators aim to study the effect of SOT in subjects with chronic lung disease in submaximal exercise.

Conditions

  • Lung Disease Chronic
  • Lung Diseases, Interstitial
  • Lung Diseases, Obstructive

Interventions

OTHER

6-minute walk distance (6MWD) test on ambient air

6-minute walk distance (6MWD) test will be performed on ambient air according to clinical standards

OTHER

6-minute walk distance test with supplemental oxygen (approximately 3l/min, nasal)

6-minute walk distance (6MWD) test will be performed according to clinical standards additionally with supplemental oxygen therapy (approximately 3l/min, nasal)

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Silvia Ulrich, Prof. Dr. · University Hospital Zurich, Department of Pulmonology

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2025-07-01
Completion
2025-07-01

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06385301 on ClinicalTrials.gov